% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • underdogs14 underdogs14 Jan 17, 2013 11:14 AM Flag

    Why are Insmed Directors buying INSM?

    Arikace does not need to prove superiority,
    It just needs to indicate its non inferiority to Tobi and Arikace will be approved for Cystic Fibrosis.

    NTM is growing 8% per year, more common than CF, no approved treatments, compassionate use this year and registration is possible with primary endpoint accomplishment.

    TB is growing out of control in India and now Eastern Europe.

    The proprietary Liposomal technology can place large and small molecule drug at the site of the infection/cancer.

    Oh yeah and IPLEX is already FDA approved.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
14.04-0.03(-0.21%)Oct 21 4:00 PMEDT